These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1963028)

  • 41. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
    Leight ER; Sugden B
    J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The expression of novel antigens from the Epstein-Barr virus large internal repeat.
    Walls D; Gannon F
    EMBO J; 1988 Apr; 7(4):1191-6. PubMed ID: 2841116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Hammerschmidt W; Sugden B
    Nature; 1989 Aug; 340(6232):393-7. PubMed ID: 2547164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of minimal oriP of Epstein-Barr virus required for DNA replication.
    Shirakata M; Hirai K
    J Biochem; 1998 Jan; 123(1):175-81. PubMed ID: 9504426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.
    Woisetschlaeger M; Jin XW; Yandava CN; Furmanski LA; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3942-6. PubMed ID: 1850841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions.
    Shah WA; Ambinder RF; Hayward GS; Hayward SD
    J Virol; 1992 Jun; 66(6):3355-62. PubMed ID: 1316452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat.
    Heller M; Flemington E; Kieff E; Deininger P
    Mol Cell Biol; 1985 Mar; 5(3):457-65. PubMed ID: 2985954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Near-zero linking difference upon transcription factor IID binding to promoter DNA.
    Lorch Y; Kornberg RD
    Mol Cell Biol; 1993 Mar; 13(3):1872-5. PubMed ID: 8382777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biosynthesis of a repressor/nuclease hybrid protein.
    Panayotatos N; Fontaine A; Bãckman S
    J Biol Chem; 1989 Sep; 264(25):15066-9. PubMed ID: 2768253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topological approaches to studies of protein-mediated looping of DNA in vivo.
    Wu HY; Liu LF
    Methods Enzymol; 1992; 212():346-51. PubMed ID: 1518454
    [No Abstract]   [Full Text] [Related]  

  • 51. Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells.
    Kintner C; Sugden B
    J Virol; 1981 Apr; 38(1):305-16. PubMed ID: 6264105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of DNA structure in vivo using psoralen photobinding: measurement of supercoiling, topological domains, and DNA-protein interactions.
    Sinden RR; Ussery DW
    Methods Enzymol; 1992; 212():319-35. PubMed ID: 1518453
    [No Abstract]   [Full Text] [Related]  

  • 53. A model for the development of the tandem repeat units in the EBV ori-P region and a discussion of their possible function.
    Karlin S; Blaisdell BE
    J Mol Evol; 1987; 25(3):215-29. PubMed ID: 2822936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A natural A/T-rich sequence from the yeast FBP1 gene exists as a cruciform in Escherichia coli cells.
    del Olmo M; Pérez-Ortín JE
    Plasmid; 1993 May; 29(3):222-32. PubMed ID: 8356116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA binding activity and inhibition of DNA-protein interactions. Differential effects of tetra-p-amidino-phenoxyneopentane and its 2'-bromo derivative.
    Nastruzzi C; Menegatti E; Pastesini C; Cortesi R; Esposito E; Spano M; Biagini R; Cordelli E; Feriotto G; Gambari R
    Biochem Pharmacol; 1992 Nov; 44(10):1985-94. PubMed ID: 1449517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA unwinding induced by nalidixic acid binding to DNA.
    Tornaletti S; Pedrini AM
    Biochem Pharmacol; 1988 May; 37(9):1881-2. PubMed ID: 3377860
    [No Abstract]   [Full Text] [Related]  

  • 57. Topological effects of EBNA 1 on oriP.
    Orlowski R; Miller G
    Adv Exp Med Biol; 1990; 278():115-24. PubMed ID: 1963028
    [No Abstract]   [Full Text] [Related]  

  • 58. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.
    Inoue N; Harada S; Honma T; Kitamura T; Yanagi K
    Virology; 1991 May; 182(1):84-93. PubMed ID: 1850915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of 12-o-tetradecanoylphorbol-13-acetate-induced cellular proteins that compete with the Epstein-Barr virus nuclear antigen 1 (EBNA-1) for binding to a site within the Epstein-Barr virus oriP.
    Nonoyama M; Wen LT; Tanaka A; Bradley G
    Adv Exp Med Biol; 1990; 278():125-36. PubMed ID: 1963029
    [No Abstract]   [Full Text] [Related]  

  • 60. Interaction of Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins.
    Wen LT; Lai PK; Bradley G; Tanaka A; Nonoyama M
    Virology; 1990 Sep; 178(1):293-6. PubMed ID: 2167556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.